Kimberly A. Workowski, MD; William C. Levine, MD; Judith N. Wasserheit, MD, MPH
Acknowledgment: The authors thank Garrett Mallory for administrative assistance.
Requests for Single Reprints: Kimberly A. Workowski, MD, Centers for Disease Control and Prevention, 1600 Clifton Road, Mailstop E02, Atlanta, GA 30333; e-mail, firstname.lastname@example.org.
Current Author Addresses: Drs. Workowski and Levine: Centers for Disease Control and Prevention, Guidelines Unit, Epidemiology and Surveillance Branch, Division of Sexually Transmitted Diseases, NCH-STP, 1600 Clifton Road, Mailstop E02, Atlanta, GA 30333.
Dr. Wasserheit: Fred Hutchinson Cancer Research Center, HIV Vaccine Trials Network, 1100 Fairview Avenue North, Mailstop D3-100, Seattle, WA 98109-1024.
Sexually transmitted diseases (STDs) constitute an epidemic of tremendous magnitude, with an estimated 15 million persons in the United States acquiring a new STD each year. Effective clinical management of STDs is a strategic common element in efforts to prevent HIV infection and to improve reproductive and sexual health. Sexually transmitted diseases may result in severe, long-term, costly complications, including facilitation of HIV infection, tubal infertility, adverse outcomes of pregnancy, and cervical and other types of anogenital cancer. The publication of national guidelines for the management of STDs, by the U.S. Centers for Disease Control and Prevention (CDC), has been a key component of federal initiatives to improve the health of the U.S. population by preventing and controlling STDs and their sequelae. This paper presents new recommendations from the 2002 CDC Guidelines for the Treatment of Sexually Transmitted Diseases in the context of current disease trends and public health.
Table 1. New Findings in the Centers for Disease Control and Prevention 2002 Guidelines for the Treatment of Sexually Transmitted Diseases
Table 2. Selected Recommendations from the Centers for Disease Control and Prevention 2002 Guidelines for the Treatment of Sexually Transmitted Diseases
The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.
Workowski KA, Levine WC, Wasserheit JN. U.S. Centers for Disease Control and Prevention Guidelines for the Treatment of Sexually Transmitted Diseases: An Opportunity To Unify Clinical and Public Health Practice. Ann Intern Med. ;137:255–262. doi: 10.7326/0003-4819-137-4-200208200-00010
Download citation file:
Published: Ann Intern Med. 2002;137(4):255-262.
Infectious Disease, Sexually Transmitted Infections.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use